Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $92,464 | $943 | $51,455 | $51,497 |
| - Cash | $16,504 | $22,866 | $9,451 | $11,472 |
| + Debt | $3,264 | $290 | $319 | $45 |
| Enterprise Value | $79,224 | -$21,634 | $42,324 | $40,069 |
| Revenue | $5,490 | $0 | $9,022 | $909 |
| % Growth | – | -100% | 892.5% | – |
| Gross Profit | $5,490 | $0 | $9,022 | $697 |
| % Margin | 100% | – | 100% | 76.7% |
| EBITDA | -$6,814 | -$8,199 | -$1,440 | -$12,243 |
| % Margin | -124.1% | – | -16% | -1,346.8% |
| Net Income | -$6,563 | -$8,169 | -$1,488 | -$11,557 |
| % Margin | -119.6% | – | -16.5% | -1,271.3% |
| EPS Diluted | -0.002 | -0.28 | -0.001 | -0.005 |
| % Growth | 99.2% | -39,900% | 85.7% | – |
| Operating Cash Flow | -$9,295 | $1,739 | -$10,459 | -$6,491 |
| Capital Expenditures | -$36 | -$2 | -$7 | -$2 |
| Free Cash Flow | -$9,331 | $1,737 | -$10,466 | -$6,493 |